1. Home
  2. RVMD vs KHC Comparison

RVMD vs KHC Comparison

Compare RVMD & KHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Revolution Medicines Inc.

RVMD

Revolution Medicines Inc.

HOLD

Current Price

$161.65

Market Cap

30.1B

Sector

Health Care

ML Signal

HOLD

Logo The Kraft Heinz Company

KHC

The Kraft Heinz Company

HOLD

Current Price

$22.83

Market Cap

28.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVMD
KHC
Founded
2014
1869
Country
United States
United States
Employees
883
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
30.1B
28.9B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
RVMD
KHC
Price
$161.65
$22.83
Analyst Decision
Strong Buy
Hold
Analyst Count
19
17
Target Price
$140.84
$24.50
AVG Volume (30 Days)
2.5M
12.4M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
7.14%
EPS Growth
N/A
N/A
EPS
N/A
0.67
Revenue
N/A
$24,942,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$533.02
$0.58
P/E Ratio
N/A
$33.98
Revenue Growth
N/A
N/A
52 Week Low
$34.00
$21.04
52 Week High
$166.50
$29.19

Technical Indicators

Market Signals
Indicator
RVMD
KHC
Relative Strength Index (RSI) 61.78 42.98
Support Level $141.22 $21.96
Resistance Level $166.50 $24.37
Average True Range (ATR) 6.70 0.59
MACD 0.20 -0.07
Stochastic Oscillator 85.99 30.75

Price Performance

Historical Comparison
RVMD
KHC

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.

About KHC The Kraft Heinz Company

In July 2015, Kraft merged with Heinz to create one of North America's largest food and beverage manufacturers. Beyond its namesake brands, its portfolio includes Oscar Mayer, Velveeta, and Philadelphia. While the retail channel drives around 85% of its total sales, the firm also maintains a growing foodservice presence. Outside North America, Kraft Heinz's global reach encompasses a distribution network in Europe and emerging markets, which accounts for around 25% of its consolidated sales base. The company's products are sold in more than 190 countries and territories.

Share on Social Networks: